Stockreport

We're Not Very Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn Rate [Yahoo! Finance]

AbCellera Biologics Inc. - Common Shares  (ABCL) 
PDF lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. Having said that, unprofitable companies are risky [Read more]